Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8485304rdf:typepubmed:Citationlld:pubmed
pubmed-article:8485304lifeskim:mentionsumls-concept:C0021831lld:lifeskim
pubmed-article:8485304lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:8485304lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:8485304lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:8485304pubmed:issue1lld:pubmed
pubmed-article:8485304pubmed:dateCreated1993-6-10lld:pubmed
pubmed-article:8485304pubmed:abstractTextTumour necrosis factor (TNF)-alpha has been implicated in the pathogenesis of experimental and clinical enteropathy, but its exact role is unknown. We show here that a single dose of TNF-alpha causes significant small intestinal pathology in normal adult mice, which develops within 15 minutes, persists for up to 48 hours and is enhanced by interferon-gamma (IFN-gamma). The enteropathy consists of villus atrophy and crypt hyperplasia and is therefore similar to that found in immunologically mediated enteropathies such as graft-versus-host reaction (GvHR). TNF-alpha is also cytotoxic to an intestinal crypt cell line in vitro. Thus, a direct action of TNF-alpha on crypt cells may be involved in its enteropathic effects in vivo. Together, these findings indicate that TNF-alpha alone, or in concert with other cytokines, may be an important effector molecule in immunologically mediated intestinal pathology and may ultimately provide a target for specific immunotherapy for clinical enteropathies.lld:pubmed
pubmed-article:8485304pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8485304pubmed:languageenglld:pubmed
pubmed-article:8485304pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8485304pubmed:citationSubsetIMlld:pubmed
pubmed-article:8485304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8485304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8485304pubmed:statusMEDLINElld:pubmed
pubmed-article:8485304pubmed:monthJanlld:pubmed
pubmed-article:8485304pubmed:issn1043-4666lld:pubmed
pubmed-article:8485304pubmed:authorpubmed-author:NicholsB LBLlld:pubmed
pubmed-article:8485304pubmed:authorpubmed-author:MowatA MAMlld:pubmed
pubmed-article:8485304pubmed:authorpubmed-author:BunceCClld:pubmed
pubmed-article:8485304pubmed:authorpubmed-author:GarsidePPlld:pubmed
pubmed-article:8485304pubmed:authorpubmed-author:TomlinsonR...lld:pubmed
pubmed-article:8485304pubmed:issnTypePrintlld:pubmed
pubmed-article:8485304pubmed:volume5lld:pubmed
pubmed-article:8485304pubmed:ownerNLMlld:pubmed
pubmed-article:8485304pubmed:authorsCompleteYlld:pubmed
pubmed-article:8485304pubmed:pagination24-30lld:pubmed
pubmed-article:8485304pubmed:dateRevised2009-9-29lld:pubmed
pubmed-article:8485304pubmed:meshHeadingpubmed-meshheading:8485304-...lld:pubmed
pubmed-article:8485304pubmed:meshHeadingpubmed-meshheading:8485304-...lld:pubmed
pubmed-article:8485304pubmed:meshHeadingpubmed-meshheading:8485304-...lld:pubmed
pubmed-article:8485304pubmed:meshHeadingpubmed-meshheading:8485304-...lld:pubmed
pubmed-article:8485304pubmed:meshHeadingpubmed-meshheading:8485304-...lld:pubmed
pubmed-article:8485304pubmed:meshHeadingpubmed-meshheading:8485304-...lld:pubmed
pubmed-article:8485304pubmed:meshHeadingpubmed-meshheading:8485304-...lld:pubmed
pubmed-article:8485304pubmed:meshHeadingpubmed-meshheading:8485304-...lld:pubmed
pubmed-article:8485304pubmed:meshHeadingpubmed-meshheading:8485304-...lld:pubmed
pubmed-article:8485304pubmed:meshHeadingpubmed-meshheading:8485304-...lld:pubmed
pubmed-article:8485304pubmed:meshHeadingpubmed-meshheading:8485304-...lld:pubmed
pubmed-article:8485304pubmed:year1993lld:pubmed
pubmed-article:8485304pubmed:articleTitleAnalysis of enteropathy induced by tumour necrosis factor alpha.lld:pubmed
pubmed-article:8485304pubmed:affiliationDepartment of Immunology, University of Glasgow, Western Infirmary.lld:pubmed
pubmed-article:8485304pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8485304pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8485304lld:pubmed